BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23284919)

  • 1. Induction of intrahepatic HCV NS4B, NS5A and NS5B-specific cellular immune responses following peripheral immunization.
    Lang Kuhs KA; Toporovski R; Yan J; Ginsberg AA; Shedlock DJ; Weiner DB
    PLoS One; 2012; 7(12):e52165. PubMed ID: 23284919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peripheral immunization induces functional intrahepatic hepatitis C specific immunity following selective retention of vaccine-specific CD8 T cells by the liver.
    Lang Kuhs KA; Toporovski R; Ginsberg AA; Olsen AL; Shedlock DJ; Morrow MP; Yan J; Wells RG; Weiner DB
    Hum Vaccin; 2011 Dec; 7(12):1326-35. PubMed ID: 22108033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strong HCV NS3/4a, NS4b, NS5a, NS5b-specific cellular immune responses induced in Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine.
    Latimer B; Toporovski R; Yan J; Pankhong P; Morrow MP; Khan AS; Sardesai NY; Welles SL; Jacobson JM; Weiner DB; Kutzler MA
    Hum Vaccin Immunother; 2014; 10(8):2357-65. PubMed ID: 25424943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-Dose Vaccination with a Hepatotropic Adeno-associated Virus Efficiently Localizes T Cell Immunity in the Liver with the Potential To Confer Rapid Protection against Hepatitis C Virus.
    Mekonnen ZA; Grubor-Bauk B; English K; Leung P; Masavuli MG; Shrestha AC; Bertolino P; Bowen DG; Lloyd AR; Gowans EJ; Wijesundara DK
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31292249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A synthetic codon-optimized hepatitis C virus nonstructural 5A DNA vaccine primes polyfunctional CD8+ T cell responses in wild-type and NS5A-transgenic mice.
    Holmström F; Pasetto A; Nähr V; Brass A; Kriegs M; Hildt E; Broderick KE; Chen M; Ahlén G; Frelin L
    J Immunol; 2013 Feb; 190(3):1113-24. PubMed ID: 23284053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Priming and stimulation of hepatitis C virus-specific CD4+ and CD8+ T cells against HCV antigens NS4, NS5a or NS5b from HCV-naive individuals: implications for prophylactic vaccine.
    Li W; Krishnadas DK; Kumar R; Tyrrell DL; Agrawal B
    Int Immunol; 2008 Jan; 20(1):89-104. PubMed ID: 18006878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus-specific cellular immune responses in sustained virological responders with viral persistence in peripheral blood mononuclear cells.
    Roque-Cuéllar MC; Sánchez B; García-Lozano JR; Praena-Fernández JM; Márquez-Galán JL; Núñez-Roldán A; Aguilar-Reina J
    Liver Int; 2014 Jul; 34(6):e80-8. PubMed ID: 24127783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent Anti-hepatitis C Virus (HCV) T Cell Immune Responses Induced in Mice Vaccinated with DNA-Launched RNA Replicons and Modified Vaccinia Virus Ankara-HCV.
    Marín MQ; Pérez P; Ljungberg K; Sorzano CÓS; Gómez CE; Liljeström P; Esteban M; García-Arriaza J
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30674625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular immunogenicity of a multi-epitope peptide vaccine candidate based on hepatitis C virus NS5A, NS4B and core proteins in HHD-2 mice.
    Huang XJ; Lü X; Lei YF; Yang J; Yao M; Lan HY; Zhang JM; Jia ZS; Yin W; Xu ZK
    J Virol Methods; 2013 Apr; 189(1):47-52. PubMed ID: 23333413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strong HCV NS3- and NS4A-specific cellular immune responses induced in mice and Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine.
    Lang KA; Yan J; Draghia-Akli R; Khan A; Weiner DB
    Vaccine; 2008 Nov; 26(49):6225-31. PubMed ID: 18692108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative analysis of the immune response to DNA constructions encoding hepatitis C virus nonstructural proteins].
    Masalova OV; Lesnova EI; Ivanov AV; Pichugin AV; Permiakova KIu; Smirnova OA; Tynitskaia VL; Ulanova TI; Burkov AN; Kochetkov SN; Ataullakhanov RI; Kushch AA
    Vopr Virusol; 2013; 58(2):21-8. PubMed ID: 23785766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Multiantigenic DNA Vaccine That Induces Broad Hepatitis C Virus-Specific T-Cell Responses in Mice.
    Gummow J; Li Y; Yu W; Garrod T; Wijesundara D; Brennan AJ; Mullick R; Voskoboinik I; Grubor-Bauk B; Gowans EJ
    J Virol; 2015 Aug; 89(15):7991-8002. PubMed ID: 26018154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of Genotype Cross-Reactive, Hepatitis C Virus-Specific, Cell-Mediated Immunity in DNA-Vaccinated Mice.
    Wijesundara DK; Gummow J; Li Y; Yu W; Quah BJ; Ranasinghe C; Torresi J; Gowans EJ; Grubor-Bauk B
    J Virol; 2018 Apr; 92(8):. PubMed ID: 29437963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-cell vaccines that elicit effective immune responses against HCV in chimpanzees may create greater immune pressure for viral mutation.
    Zubkova I; Choi YH; Chang E; Pirollo K; Uren T; Watanabe H; Wells F; Kachko A; Krawczynski K; Major ME
    Vaccine; 2009 Apr; 27(19):2594-602. PubMed ID: 19428866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [DNA immunization with a plasmid containing gene of hepatitis C virus protein 5A (NS5A) induces the effective cellular immune response].
    Masalova OV; Lesnova EI; Grabovetskiĭ VV; Smirnova OA; Ulanova TI; Burkov AN; Ivanov AV; Zaberezhnyĭ AD; Ataullakhanov RI; Kushch AA
    Mol Biol (Mosk); 2010; 44(2):275-83. PubMed ID: 20586188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus polyprotein vaccine formulations capable of inducing broad antibody and cellular immune responses.
    Vajdy M; Selby M; Medina-Selby A; Coit D; Hall J; Tandeske L; Chien D; Hu C; Rosa D; Singh M; Kazzaz J; Nguyen S; Coates S; Ng P; Abrignani S; Lin YL; Houghton M; O'Hagan DT
    J Gen Virol; 2006 Aug; 87(Pt 8):2253-2262. PubMed ID: 16847121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40.
    Zabaleta A; Arribillaga L; Llopiz D; Dotor J; Lasarte JJ; Prieto J; Borrás-Cuesta F; Esteban JI; Quer J; Vayreda F; Sarobe P
    Antiviral Res; 2007 Apr; 74(1):25-35. PubMed ID: 17275104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA prime-canarypox boost with polycistronic hepatitis C virus (HCV) genes generates potent immune responses to HCV structural and nonstructural proteins.
    Pancholi P; Liu Q; Tricoche N; Zhang P; Perkus ME; Prince AM
    J Infect Dis; 2000 Jul; 182(1):18-27. PubMed ID: 10882577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preservation of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses despite global loss of CD4+ T cells in HCV/HIV coinfection.
    Morishima C; Shuhart MC; Yoshihara CS; Paschal DM; Silva MA; Thomassen LV; Emerson SS; Gretch DR
    J Infect Dis; 2007 Aug; 196(4):577-86. PubMed ID: 17624844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus NS3/NS4A DNA vaccine induces multiepitope T cell responses in rhesus macaques mimicking human immune responses [corrected].
    Lang Kuhs KA; Ginsberg AA; Yan J; Wiseman RW; Khan AS; Sardesai NY; O'Connor DH; Weiner DB
    Mol Ther; 2012 Mar; 20(3):669-78. PubMed ID: 21952169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.